GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
58.93
+0.39 (0.67%)
At close: Feb 13, 2026, 4:00 PM EST
59.30
+0.37 (0.63%)
After-hours: Feb 13, 2026, 7:40 PM EST
GSK Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for GSK in the last 12 months.
Price Target: n/a
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GSK stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 2 | 2 | 2 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 3 | 3 | 3 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Jan 6, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Initiates n/a | Hold → Strong Buy | Initiates | n/a | n/a | Oct 27, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
Financial Forecast
Revenue This Year
35.19B
from 32.67B
Increased by 7.72%
Revenue Next Year
36.80B
from 35.19B
Increased by 4.59%
EPS This Year
1.87
from 1.39
Increased by 34.76%
EPS Next Year
2.03
from 1.87
Increased by 8.58%
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 37.4B | 41.3B | |||
| Avg | 35.2B | 36.8B | |||
| Low | 32.8B | 34.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.6% | 17.4% | |||
| Avg | 7.7% | 4.6% | |||
| Low | 0.3% | -2.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.07 | 2.44 | |||
| Avg | 1.87 | 2.03 | |||
| Low | 1.58 | 1.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 49.1% | 30.5% | |||
| Avg | 34.8% | 8.6% | |||
| Low | 13.5% | -9.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.